James Atkins, MD
Otolaryngology · San Antonio, TXNPI 1396730776
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $187,038 of the $204,979 with a category attached, or 91.2%. Medical Device Business Services, Inc. accounts for 69.0% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $89,478 and has fallen 98.7% since, to $1,195 in 2025. Among otolaryngology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 369 payments — averaging $555.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$141K
- Acclarent, Inc$50K
- Aerin Medical Inc.$5K
- Smith+Nephew$3K
- Regeneron Healthcare Solutions, Inc.$2K
- Sanofi$711
- plus $2K from 16 others
Across 1 payment — averaging $4000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Acclarent, Inc$4K
What the payments were for
- Consulting fees$187,03891%
- Travel & lodging$7,9134%
- Food & beverage$10,0285%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 60 | $141,399 |
| Acclarent, Inc | 113 | $50,094 |
| Aerin Medical Inc. | 24 | $5,486 |
| Smith+Nephew | 3 | $3,201 |
| Regeneron Healthcare Solutions, Inc. | 63 | $1,759 |
| Sanofi | 27 | $711 |
| Medtronic | 16 | $628 |
| Optinose US, Inc. | 24 | $523 |
| Sanofi-aventis U.S. LLC | 16 | $345 |
| Intersect ENT, Inc. | 3 | $278 |
| Stryker | 2 | $124 |
| Arrinex, Inc. | 1 | $117 |
| Alk-abello, Inc | 5 | $76 |
| Hikma Pharmaceuticals USA | 3 | $50 |
| Kaleo, Inc. | 2 | $49 |
| Vertex | 1 | $29 |
| GSK | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Merck | 1 | $19 |
| Integra Lifesciences Corporation | 1 | $17 |
| 3-d Matrix, Inc. | 1 | $15 |
| Mylan Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TruDi Nav Suction$51,852
- TruDi Navigation System$46,405
- ACCLARENT NAVWIRE Sinus Navigation Guidewire$34,424
- TruDi Nav Cable$33,863
- ACCLARENT Balloon Inflation Device$29,729
- SpinPlus Navigation$18,675
- TruDi$5,986
- VivAer$5,000
- RhinAer$5,000
- ACCLARENT AERA EUSTACHIAN TUBE BALLOON DILATION SYSTEM$3,954
- REFLEX ULTRA Turbinate Wands$3,150
- Acclarent Navwire$584
- Acclarent ENT Navigation System$338
- PROPEL$256
- DUPIXENT$250
- VenSure Balloon Dilation System$149
- RELIEVA SpinPlus NAV Balloon Sinusplasty System$132
- CLARIFIX$117
- ENTELLUS - XPRESS ENT DILATION SYSTEM$101
How this compares
$204,979 in reported general payments places this provider in the 95th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 50 | $204,107 |
| Dupixent SyringeDupilumab | 22 | $79,943 |
| Flucytosine | 17 | $44,930 |
| Ipratropium Bromide | 217 | $5,965 |
| Cefdinir | 91 | $3,008 |
| Azelastine Hcl | 95 | $2,743 |
| Mupirocin | 24 | $1,205 |
| Methylprednisolone | 94 | $637 |
| Doxycycline Hyclate | 40 | $534 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 32 | $463 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $268 |
| Azithromycin | 46 | $185 |
| Omeprazole | 16 | $172 |
| Prednisone | 33 | $57 |
| Gabapentin | 38 | $23 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in San Antonio
- Philip ChenSan Antonio$305K
- Jeffrey RosenbloomSan Antonio$23K
- Jay FerrellSan Antonio$19K
- Marc DeanFort Worth$486K
- Amber LuongHouston$426K
- Arjuna KuperanHouston$348K
- Ronald KuppersmithCollege Station$325K
- Ron KarniHouston$317K
- Jordan RihaniSouthlake$280K
- Keith MathenyFrisco$269K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.